09.09.2014 Views

Autism Studies and Related Medical Conditions, January 2009 - TACA

Autism Studies and Related Medical Conditions, January 2009 - TACA

Autism Studies and Related Medical Conditions, January 2009 - TACA

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

PMID: 1307234 [PubMed - indexed for MEDLINE]<br />

Schectman G, Byrd JC, Hoffmann R. Ascorbic acid requirements for smokers: analysis of<br />

a population survey. Am J Clin Nutr. 1991 Jun;53(6):1466-70.<br />

Division of General Internal Medicine, <strong>Medical</strong> College of Wisconsin, Milwaukee<br />

53226.<br />

The recommended dietary allowance (RDA) of ascorbic acid for smokers was<br />

recently increased from 60 to 100 mg. To determine whether this new RDA for<br />

smokers is sufficient to reduce the risk of low serum ascorbic acid (AA)<br />

concentrations (LoC) to the same concentration as nonsmokers, we analyzed the<br />

dietary intakes <strong>and</strong> serum concentrations of AA in 11,582 adult respondents in<br />

the National Health <strong>and</strong> Nutrition Examination Survey (1976-1980). Serum AA<br />

concentrations <strong>and</strong> the risk of LoC (serum ascorbic acid levels less than 23<br />

mumol/L) for smokers consuming different amounts of AA were compared with<br />

those for nonsmokers whose AA intake exceeded the RDA (60 mg). Serum AA<br />

concentrations were reduced, <strong>and</strong> risk of LoC increased, in smokers maintaining<br />

AA intakes greater than 60, 100, <strong>and</strong> 150 mg. Only smokers consuming greater<br />

than 200 mg AA/d had serum ascorbate concentrations <strong>and</strong> risk of LoC<br />

equivalent to nonsmokers meeting the RDA.<br />

PMID: 2035475 [PubMed - indexed for MEDLINE<br />

Schoon EJ, Muller MC, Vermeer C, Schurgers LJ, Brummer RJ, Stockbrugger RW. Low<br />

serum <strong>and</strong> bone vitamin K status in patients with longst<strong>and</strong>ing Crohn's disease: another<br />

pathogenetic factor of osteoporosis in Crohn's disease? Gut. 2001 Apr;48(4):473-7.<br />

Department of Gastroenterology <strong>and</strong> Hepatology, University Hospital Maastricht,<br />

Maastricht, the Netherl<strong>and</strong>s. ESCH@sint.azm.nl<br />

BACKGROUND: A high prevalence of osteoporosis is reported in Crohn's disease.<br />

The pathogenesis is not completely understood but is probably multifactorial.<br />

Longst<strong>and</strong>ing Crohn's disease is associated with a deficiency of fat soluble<br />

vitamins, among them vitamin K. Vitamin K is a cofactor in the carboxylation of<br />

osteocalcin, a protein essential for calcium binding to bone. A high level of<br />

circulating uncarboxylated osteocalcin is a sensitive marker of vitamin K<br />

deficiency. AIMS: To determine serum <strong>and</strong> bone vitamin K status in patients with<br />

Crohn's disease <strong>and</strong> to elucidate its relationship with bone mineral density.<br />

METHODS: Bone mineral density was measured in 32 patients with longst<strong>and</strong>ing<br />

<strong>Autism</strong> <strong>Studies</strong> & <strong>Related</strong> <strong>Medical</strong> <strong>Conditions</strong> – <strong>TACA</strong> © Page 215

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!